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Abstract
Objective: To evaluate the beneﬁt of using three-dimensional transesophageal echocardiography (3DTEE) over conventional two-dimensional transesophageal echocardiography (2DTEE) in evaluation of various morphological features
of atrial septal defect (ASD) and patent foramen ovale (PFO) during transcatheter closure.
Methods: This is an observational cross sectional study including 115 patients (45 PFO and 70 ASD patients) who
underwent 2D/3DTEE guided transcatheter closure from April 2019 to October 2021 in cardiology department, Tanta
university hospital.
Results: 70 ASD patients were divided into two groups; the pediatric age group (18 patients, mean age 9.05 ± 3.51 years)
and the adult group (52 patients, mean age 39.3 ± 10.15 years). ASD morphology was simple in 12.9% and complex in
87.1% of patients, where 3DTEE was superior in the evaluation of posterior, infero posterior rims, fenestrated ﬂimsy
rims, aneurysm shape, orientation, and quality of its tissue. Procedural success was deﬁned as complete defect closure
with no complications. The procedure was successful in 68 and failed in 2 patients.
45 PFO patients were divided into two groups; the pediatric age group (14 patients, mean age 13.5 ± 3.25 years) and the
adult group (31 patients, mean age 35.2 ± 4.5 years). PFO morphology was simple in 22.2% and complex in 77.8% of
patients, where 3DTEE was superior in the evaluation of the exact PFO opening from the left atrium, additional fenestrations, aneurysm shape, orientation, and quality of its tissue. The procedure was successful in all patients.
Conclusion: 3DTEE guided transcatheter ASD/PFO closure provides an additional value over conventional 2DTEE in
assessment of complex ASD/PFO morphology.
Keywords: Atrial septal defect, Patent foramen ovale, Real-time 3-dimensional transesophageal echocardiography

1. Introduction

M

eticulous morphological evaluation of atrial
septal defect (ASD) and patent foramen ovale
(PFO) is the cornerstone for appropriate device selection. Two-dimensional transesophageal echocardiography (2DTEE) has traditionally been used for
dynamic evaluation of the interatrial septum (IAS);

however, it requires multiple views due to complex
septal three-dimensional structure [1,2].
Real-time three-dimensional transesophageal
echocardiography (RT-3DTEE) demonstrates ASD/
PFO morphology and their relationship to the surrounding structures in a single enface view without
the need for mental reconstruction. It also clariﬁes
the dynamic change in defect size during the cardiac
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cycle and directly visualizes bubbles crossing PFO
tunnel to exclude extracardiac shunts [2e4].
RT3DTEE facilitates monitoring of the position of
wires, catheters, as well as, the occluder device, and
its relation to the surrounding structures. RT3DTEE
has enhanced both pre-procedural planning and
intra-procedural guidance [1].
The aim of this study was to evaluate the additional beneﬁt of 3DTEE over conventional 2DTEE
during ASD/PFO transcatheter closure.

2. Methods
This is an observational cross-sectional study
including 115 patients (45 PFO and 70 ASD patients)
who underwent 2D/3DTEE guided transcatheter
closure from April 2019 to October 2021 in cardiology department, Tanta University Hospital.
2.1. Inclusion criteria
1. ASD secundum defects (amenable for device
closure with evidence of either haemodynamic
signiﬁcance or embolic complications) [5].
2. PFO inducing cryptogenic cortical events
together with high Risk Of Paradoxical Embolism (ROPE) score 7 (in patients 18 years)
after conﬁrmation of right to left shunt by
transcranial Doppler [TCD] and TEE.
2.2. Exclusion criteria
1. Irreversible pulmonary vascular disease
2. Other causes of stroke e.g atherosclerotic cerebrovascular disease, thrombophilia and atrial
ﬁbrillation [6e12].
After approval from the ethical committee of
Faculty of Medicine, Tanta University, an informed
consent was obtained from all participants by
themselves or their parents after a full explanation
of the beneﬁts and risks of the study.
Pre-procedural planning was made using transthoracic echocardiography (TTE), 2DTEE and
3DTEE to conﬁrm the suitability for device closure.
The procedure was done under general anaesthesia
guided by ﬂuoroscopy and 2DTEE/3DTEE using matrix-array 3DTEE probe (GE 6VT-D), and (Vivid E9,
General Electric Corporation, USA) machine.
2.3. 2DTEE
Multiple 2DTEE views; Mid-esophageal fourchamber, mid-esophageal aortic valve short-axis
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and bicaval views were used to evaluate ASD/PFO
morphology [13e15].
1- ASD morphology: was simple in 9 patients
(12.9%) and complex in 61 patients (87.1%).
Complex ASDs included: large defects in 20 patients (large for body surface area in pediatric age
group or more than 30 mm in adults), deﬁcient rims
in 50 patients (less than 5 mm), small left atrium size
for body surface area in 10 patients, and ﬂimsy (thin
ﬂoppy) rims in 15 patients [16].
ASD was associated with: PFO (hybrid defects) in 10
patients (14.3%), atrial septal aneurysm (ASA)
(denoting excessive mobility of IAS with an excursion more than 10 mm in either direction from
septal plane or more than 15 mm total excursion
between both atria) in 30 patients (42.9%) [17,18].
ASA was multi-fenestrated in 6 patients. Prominent
Eustachian valve (EV) was present in 11 patients
(15.7%).
2- PFO morphology: was simple in 10 patients
(22.2%) and complex in 35 patients (77.8%). Complex PFO included: ASA in 15 patients, thick secondary septum (more than 10 mm) in 10 patients
and long tunnel (more than or equal to 12 mm) in 14
patients. Prominent EV was present in 16 patients
and dilated aortic root in 2 patients [17e19].

Agitated saline was injected to conﬁrm right to left
shunt in cases of PFO, ASD associated with PFO
(hybrid defects), ASA and in presence of large
Eustachian valve. The test was considered positive
when a large number of bubbles passed across the
PFO to the left atrium (LA) within the ﬁrst 3 cardiac
cycles [17].
2.4. 3DTEE
Using the same Vivid E9 machine, evaluation
included; Live 3D and 3D zoom of the IAS using
TUPLE (tilt up then left) plus ROLZ (rotate left in zaxis) maneuver. The area of interatrial septum was
selected in bicaval view to obtain a 3D zoom image
that was tilted up to view the septum from the right
atrial perspective with superior vena cava (SVC)
located at the right side of the screen. Then, the image
was rotated to the left by 90 in the z-axis. After that, it
was tilted to the left around its vertical axis to obtain
the view of the IAS from LA perspective [20].
Cropping was performed to remove the surrounding structures, image gain was adjusted and,
enface view of IAS was obtained [20,21].
Mid-esophageal aortic short axis view was used
for procedural guidance using Zoom and 3D live
modes.
Volume rendered data was analyzed to visualize
ASD/PFO, relation to the surrounding structures,
dimensions (measured in end-systolic frame of the
cardiac cycle, Flexi-slice software), defect shape,
rims, position, other fenestrations, and associated
ASA [1e4,22e25] (Figs. 1e4).
During 3DTEE examination, bubble study was
repeated in patients with positive 2DTEE study
while looking from LA enface view, to conﬁrm
shunting through PFO itself.
2.5. Transcranial Doppler (TCD)
TCD was performed in all patients with right to
left shunt by TEE, TCD is graded as: (grade 1): no
occurrence of micro-bubbles (MB); (grade 2):
1e10 MB: (grade 3) > 10 MB, but no curtain, and
(grade 4): curtain, where a single MB cannot be
discriminated [26]. Grades 3 and 4 were considered
as signiﬁcant right to left shunt.
2.6. Transcatheter closure
It was performed under general anaesthesia.
Right femoral venous access was obtained using
Sildenger technique, heparin (100 IU/Kg) keeping
activated clotting time (ACT) > 200 s and antibiotics
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were administered. In case of mobile Eustachian
valve, it was held against right atrial wall using a
steerable ablation catheter (Boston Scientiﬁc/
Vascular, Quincy, MA) introduced through another
venous access on the opposite side [27e29].
Both ﬂuoroscopic and 2D/3DTEE guidance were
used to visualize passage of catheters, wires and
delivery sheath across the defect into the LA. The
device was prepared in heparinized saline, then
advanced through the long sheath to LA. 3D data set
was rotated during device deployment to provide
simultaneous views from both atria using 3D zoom
and live 3D modes (Fig. 5).
In ASD patients with signiﬁcant pulmonary hypertension (10 patients with systolic pulmonary artery pressure >50 mmHg), calculation of pulmonary
vascular resistance (PVR) was done, all patients
were candidate for closure (pulmonary vascular
resistance was less than 5 WU and ﬁnal PVR: SVR
ratio was <0.33). After closure, the device wasn't
immediately released but kept connected to the
cable with close haemodynamic monitoring; they
didn't develop any heart failure signs or hemodynamic compromise.
Choice of the device
ASD patients; Atrial septal occluder (ASO) was
chosen according to the maximum TEE diameter
(1e4 mm larger than defect size), considering the
total IAS length. Cribriform device was used in case
of multi-fenestrated ASDs with appreciable tissue
thickness. Tissue thickness, rims and associated
fenestrations could be assessed in single view using
3DTEE [30].
Regarding PFO Patients; Larger PFO occluders were
used in the presence of a long tunnel or ﬂoppy
primum septum [30e32].
Immediate post deployment and release, 2DTEE/
3DTEE evaluation was done to assess residual leaks,
device embolization or malposition. After that, patients joined regular TTE follow-up schedule (before
discharge, after 1 week, 1 month, 6 months and
yearly).
Procedural success was deﬁned as complete
defect closure with no complications. Procedural
failure was deﬁned as abortion of the procedure or
device embolization.
Medications
A) Aspirin 3e5 mg/kg/day for 6 months and clopidogrel for 1e3 months (in patients with PFO, large
ASDs or in the presence of large EV).
B) Endocarditis prophylaxis for 6 months after
closure
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Fig. 1. ASD assessment by both TEE modalities; (a-b, Patient No.15) a) 3DTEE: RA enface view, ﬂimsy fenestrated posterior and IVC rims (arrow), b)
3DTEE; Defect measurement using Flexi-slice software. (c-f, Patient No. 20) c) 2DTEE: Absent aortic rim, deﬁcient posterior rim, d) 2DTEE: Deﬁcient
IVC rim, e) 3DTEE: RA enface view, absent aortic rim, short just efﬁcient posterior and IVC rims. f) 3DTEE: dynamic change of ASD size with cardiac
cycle. (g-h, Patient No. 23) g) 2DTEE: Small centralized ASD secundum with turbulent left to right shunt. h) 3DTEE: Enface view from RA, small
centralized circular defect with long Eustachian valve (arrow). (IVC: inferior vena cava, RA: right atrium)
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Fig. 2. Includes patients in whom procedure failed; (a-d Patient No.47) a) 2DTEE: multifenestrated ASA, b) 3DTEE; RA enface showing cone shaped
multifenestrated ASA with apparently tough septal tissue (arrow), c) 2DTEE: Device couldn't encroach the aneurysm with signiﬁcant residual shunt
(arrow), d) 3DTEE; Widely spaced device discs. (e-j Patient No. 3), e) 2DTEE: Double inter-atrial septae enclosing a midline chamber (arrow), f)
2DTEE: Restrictive RA fenestration (arrow), g) 3DTEE; LA enface view showing the opening of the chamber from LA (arrow), h) RA enface view
showing the opening of the chamber from RA (arrow), i) 2DTEE: No contrast passage from RA to LA, j) angiographic view showing no contrast
passage after failed multiple trial of crossing of interatrial septum. (ASA: atrial septal aneurysm, LA: left atrium, RA: right atrium)

2.7. Statistical analysis
Data were analyzed using the IBM® SPSS statistical
soft-ware, version 21. Numerical data were presented
as mean and standard deviation and categorical data
were presented as number and percentage.
Chi-square test was used for comparing the
qualitative data. Paired t test was used to compare
the two means between 2DTEE& 3DTEE in the
same groups. The level of signiﬁcance was adopted
at p < 0.05.

Logistic Linear regression was used to detect the
predictor variables most affected by using 3DTEE.

3. Results
3.1. ASD group
A- Pediatric age group: included 18 patients with
age ranged from (5e18) years; the mean age was
9.05 ± 3.51 years, and the mean weight was
43.3 ± 16.45 Kg. They presented with dyspnea
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Fig. 2. (continued).

(NYHA class II) in 12 patients (66.7%), palpitation
(with no documented arrhythmia) in 11 patients
(61.1%), and repeated chest infections in 8 patients
(44.4%).
B- Adult group: included 52 patients with age
ranged from (22e55) years; the mean age was
39.3 ± 10.15 years and the mean weight was
86.3 ± 9.85 kg. 33 patients (63.5%) presented with
palpitation (with no documented arrhythmia), 29
patients (55.8%) with dyspnea (NYHA class II-III), 5
patients (9.6%) with transient ischemic attack (TIA)
and 2 patients (3.8%) with cryptogenic stroke.
2DTEE was compared to 3DTEE in both pediatric and
adult ASD groups
1- ASD Measurements: There was no signiﬁcant
difference between ASD measurement by both
modalities, the mean minimum ASD diameter
measured by 2DTEE was 16.41 ± 5.25 mm and by
3DTEE was 16.71 ± 5.36 mm (P value 0.27). The
mean maximum ASD diameter measured by 2DTEE
was 23.32 ± 6.67 mm and by 3DTEE was
23.54 ± 7.26 mm (P value 0.38).
2- ASD Shape: Both modalities were signiﬁcantly
different (Table 1). Multiple 2DTEE views were
needed to assume ASD shape. ASD was considered
circular if the difference between its diameters was
<1e2 mm, mental reconstruction was needed for

assumption of its shape. However, with a single
3DTEE enface view of IAS, we could appreciate ASD
shape.
3DTEE demonstrated the complex shape in (patient number 3) who had double atrial septae
enclosing an interatrial chamber (Fig. 2 e-j).
3-ASD Position: There was no signiﬁcant difference
between both modalities. Multiple 2DTEE views
were needed to evaluate ASD rims to assume
whether the defect was central or eccentric. A single
3DTEE enface view of IAS could instantly demonstrate ASD position (Table 1).
4- ASD Rims: were much easily evaluated in a single
enface view from both RA and LA perspectives using
3DTEE. 3DTEE was beneﬁcial in 11 patients with
deﬁcient posterior and inferior vena cava (IVC) rims
by 2DTEE, using 3DTEE, they looked just efﬁcient
with appreciable tissue deserving trial of device
closure. Regarding other rims, there was no signiﬁcant difference between both modalities (Table 1).
Flimsy (thin ﬂoppy) rims were present in 15 patients (21.4%), 3DTEE was more superior in detection of fenestrations within these rims (8 patients
with 3DTEE; 2 patients with 2DTEE) with signiﬁcant
P-value (0.03). This has also affected our decision
making in device sizing as these defects needed
oversizing of the occluder device to cover these
weak fenestrated rims.
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Fig. 3. PFO assessment by 3DTEE. a) RA enface, appearance of fossa ovalis (arrow), (patient No. 2), b) Contrast coming out of PFO opening (arrow)
(patient No.5), c) Long PFO tunnel (patient No.26), d) Measurement of PFO tunnel using Flexi-slice software (patient No.24), e) Long Eustachian
valve (arrow).(patient No.38), f) Atrial septal aneurysm seen from RA perspective with associated small fenestration (arrow).(patient No.34). (LA: left
atrium, RA: right atrium)

5- Aneurysmal ASDs: 30 patients had associated
ASA. 3DTEE was beneﬁcial in the assessment of
(Table 2):
 Aneurysm shape: oval or circular.
 Orientation: vertical, horizontal, or oblique according to ASA long axis.
 Tissue thickness: that was beneﬁcial in determining the device size and type with no need for
balloon sizing. In the case of soft aneurysmal
tissue, we oversized the device. Tough thick
multi-fenestrated ASA was detected in patient
number 47 (Fig. 2 a-d).

Devices used: Atrial septal occluders were used in
66 patients with sizes ranging from 6 to 40 mm, and
mean 27.71 ± 9.36 mm. Cribriform device was used
in 4 patients with aneurysmal multi-fenestrated
ASDs and appreciable aneurysmal tissue; the device
size ranged from 25 to 35 mm, and mean
28.75 ± 1.25 mm.
Procedural Success: procedure was aborted in 2
patients
- Patient number 47 had a cone shaped, multifenestrated ASA; its tissue looked thick and tough
during evaluation with 3DTEE. After cribriform
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device deployment, it couldn't include such tough
ASA tissue in between its two discs with signiﬁcant
residual shunt; the device was removed, procedure
was aborted, and patient was referred for surgery
Fig. 2 (a-d).
- Patient number 3 presented with cryptogenic
stroke and double atrial septum due to accessory
septal tissue forming an interatrial chamber. Several
trials of crossing this chamber failed due to its
restrictive right atrial oriﬁce resulting in procedural
failure, and patient was kept on anticoagulation
Fig. 2 (e-j).
3DTEE was beneﬁcial in the demonstration of such
complex atrial septal morphology
Logistic linear regression analysis was done to
determine ASD parameters having the most beneﬁt
from using 3DTEE. It was signiﬁcant in evaluation of
posterior rim, IVC rim, ASDs with associated certain
morphological features e.g. ASA and PFO, and in
presence of additional fenestrations within the
ﬂimsy rims (Table 3).

3.2. PFO group
A- Pediatric age group: included 14 patients with
age ranged from (6e18) years; the mean age
was13.5 ± 3.25 years and mean weight was
57.9 ± 15.65 Kg. They presented clinically with
TIA in 5 patients (35.7%), cryptogenic stroke in 4
patients (28.6%) and TIA associated with migraine
in 5 patients (35.7%). TCD results were Grade 3 in
6 patients (42.9%) and Grade 4 in 8 patients
(57.1%).
B- Adult group: included 31 patients with age
ranged from (23e49) years; the mean age was
35.2 ± 4.5 years and the mean weight was
74.5 ± 9.85 kg. They presented clinically with TIA in
13 patients (41.9%), cryptogenic stroke in 5 patients
(16.1%), TIA associated with migraine in 7 patients
(22.6%) and cryptogenic stroke associated with
migraine in 6 patients (19.4%). ROPE score ranged
from (7e10), with a mean 8.44 ± 1.71. TCD results
were Grade 3 in 12 patients (38.7%) and Grade 4 in
19 patients (61.3%).

Fig. 4. Left atrial pouch and ridge assessment by 2DTEE/3DTEE. a) 2DTEE: Left atrial pouch with lack of complete fusion between primum and
secundum septae, b) No passage of contrast across interatrial septum, c) 3DTEE: Lack of complete fusion between primum and secundum septae, only
at the tip of PFO tunnel (arrow), d) 3DTEE: Left atrial ridge representing thickened tissue along fossa ovalis (arrow).

93
ORIGINAL ARTICLE

JOURNAL OF THE SAUDI HEART ASSOCIATION 2022;34:85e99

Fig. 5. 3DTEE procedural guidance of ASD/PFO closure, a) MP catheter crossing the ASD (arrow), b) Catheter is seen crossing PFO tunnel (arrow), c)
Catheter is seen in LUPV (arrow), d) Delivery sheath crossing the ASD, e) Deployment of ASO left disc (arrow), f) Deployment of ASO right disc
(arrow), g) PFO device deployment, h) ASO seen from LA perspective, i) LA enface view, well seated PFO device, j) ASO in good position sandwiching
aortic valve, k) Relation of PFO device to aortic valve, l) No passage of contrast after PFO device release. (ASO: atrial septal occluder, MP:
multipurpose catheter, LA: left atrium, LUPV: left upper pulmonary vein).

2DTEE was compared to 3DTEE in both pediatric
and adult PFO groups
1- PFO tunnel measurements: there was no signiﬁcant difference between both modalities as regards
tunnel length, but PFO width measurement was
signiﬁcantly larger by 3DTEE (Table 4)
2- PFO rims: both modalities showed no signiﬁcant
difference (Table 4)
3- Aneurysmal PFOs: ASA was present in 15 patients (33.3%). 3DTEE was beneﬁcial in assessment
of (Table 2):






Aneurysm shape.
Orientation.
Tissue thickness.
Additional fossa ovalis fenestrations: 3DTEE was
more superior in their detection (1 patient with
2DTEE, 7 patients with 3DTEE) with signiﬁcant
p-value. (0.03)
 Evaluation of tissue thickness and other fenestrations was beneﬁcial in device sizing; larger
devices were needed in case of ﬂoppy thin
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Fig. 5. (continued).

aneurismal tissue and in the presence of other
fenestrations to be covered by the occluder.
Procedural Success: Procedure was successful in all
patients with no complications.
3DTEE was helpful in the exclusion of a patient
with left atrial pouch with fused PFO tunnel (Fig. 4).
Logistic Linear regression analysis was signiﬁcant
for evaluation of additional fossa ovalis fenestrations (Table 5).

3.3. Role of 3DTEE in procedural guidance
3DTEE provided optimum monitoring of all procedural steps through visualization of catheters and
guide wires passing through the defect into the left
atrium up to the pulmonary vein, followed by the
delivery sheath, and device deployment. 3DTEE
also conﬁrms good device position and its spatial
orientation in relation to the surrounding structures
to exclude encroachment on any of them (Fig. 5).

Table 1. Assessment of ASD shape, position, and rims by 2DTEE and
3DTEE.
shape of ASD

X2
P. value

2D
TEE
(n ¼ 70)

3D
TEE
(n ¼ 70)

No.

%

No.

%

Oval
Rounded
Irregular
Double septum

63
6
0
1

90%
8.6%
0.0%
1.4%

40
13
16
1

57.1%
18.6%
22.9%
1.4%

23.7
(0.001*)

Position of ASD

2D
TEE
(n ¼ 70)
No. %

3D
TEE
(n ¼ 70)
No. %

X2
P. value

central
eccentric anterosuperior
eccentric posteroinferior

33
25
12

29
27
14

2.25
(1.32)

Rim

2D
TEE
(n ¼ 70)
No. %

3D
TEE
(n ¼ 70)
No. %

X2
P. value

68
2
68
2
46
24
47
23
35
20
15

68
2
70
0
57
13
58
12
35
26
9

e

AV Rim
SVC Rim
Post Rim
IVC Rim
Aortic Rim

Sufﬁcient
Malaligned
Sufﬁcient
Deﬁcient
Sufﬁcient
Deﬁcient
Sufﬁcient
Deﬁcient
Sufﬁcient
Deﬁcient
Absent

47.1%
35.7%
17.1%

97.1%
2.9%
97.1%
2.9%
65.7%
34.3%
67.1%
32.9%
50%
28.6%
21.4%

41.4%
38.6%
20%

97.1%
2.9%
100%
0.0%
81.4%
18.6%
82.9%
17.1%
50%
37.1%
12.9%

1.25
(0.25)
7.25
(0.01*)
8.23
(0.05*)
1.25
(0.32)

X2: chi square test *: Statistically signiﬁcant at p  0.05.

4. Discussion
RT-3DTEE guidance offers the potential for
shorter and safer interventional procedures [33].
3DTEE images can be obtained in different modes:
biplane, full-volume, live 3D, and 3D zoom imaging,
which is the most beneﬁcial because it provides
instantaneous images of the entire IAS [20].
This study aimed to evaluate the beneﬁt of using
3DTEE over conventional 2DTEE during ASD/PFO
transcatheter closure.
3DTEE uses volume datasets that can be sliced
into different planes after acquisition. The multiplanar reconstruction (MPR) technique (known as
Flexi-slice in GE system) providing all the needed
information in a single view [34e39].
4.1. ASD group
1- ASD measurement; There was no signiﬁcant
difference between both modalities. Hascoet S.,
et al. and Contreras A.E., et al. also reported nonsigniﬁcant difference of ASD size between both
modalities, and both correlated well with balloon
sizing [37,38].

2- ASD Shape and position: 3DTEE demonstrated
ASD shape and position in a single 3D ‘enface’ view.
Roberson D.A., et al. reported concordance between
3DTEE with surgical inspection regarding ASD
shape [35].
ASD patient number 3 presented with cryptogenic
stroke and double atrial septum, further clariﬁed by
3DTEE. Robaei et al., Alobaidan et al., Vijaykumar
Reddy et al., described such anatomy and its relation to cryptogenic stroke [40e42].
Manabu Taniguchi et al. reported that 3DTEE is
superior to 2DTEE in ASD position assessment [43].
3-Rims: were easily evaluated in single enface
view from both RA and LA using 3DTEE without the
need for mental reconstruction. Deﬁcient posterior
and IVC rims by 2DTEE actually looked just sufﬁcient by 3DTEE with appreciable tissue in 11 patients. So, the decision changed from surgery to trial
of device closure and procedure was successful in
all of them. Vinay K Sharma et al. reported that
3DTEE is better in the evaluation of ASD rims than
2DTEE [15].
4- Evaluation of tissue thickness of ASA in aneurysmal
ASDs: 3DTEE was useful in evaluation of ASA tissue
thickness. This is in agreement with Taha. F and
ElShedoudy. S [20], In the case of soft aneurysmal
tissue, we had to oversize the device. ASD patient
number 47 had thick ASA that couldn't be included
in between the device discs.
4.2. PFO group
3DTEE provided accurate PFO diagnosis through
direct visualization of the bubbles coming out from
PFO opening differentiating intracardiac from extracardiac shunts [3].Tanaka J et al. also reported that
3DTEE PFO width measurement was larger than
2DTEE, and there was no signiﬁcant difference between tunnel length measured by both modalities
[32].
Table 2. Description of ASA Shape, Orientation, and Tissue thickness in
ASD/PFO patients using 3DTEE.
3D TEE

Shape

Tissue

Orientation

Oval
Circular
cone shaped
Soft
Appreciated
Tough
Vertical
Horizontal
Oblique

Aneurysmal
ASD patients
(n ¼ 30)

Aneurysmal
PFO patients
(n ¼ 15)

No.

%

No.

%

24
5
1
21
8
1
11
4
9

80%
16.7%
3.3%
70%
26.7%
3.3%
36.7%
13.3%
30%

9
6
0
5
10
0
4
3
2

60%
40%
0.0%
33.3%
66.7%
0%
26.7%
20.0%
13.3%
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Table 3. Linear Regression Analysis to determine ASD parameters most affected by using 3D TEE.
Predictor variables

standardized coefﬁcients

T

P value

R square
(effect)

2.150.36
2.012.5
2.01
19.05
2.5
10.01
0.523.03
1.23
4.68-

0.15
0.24
0.14
0.27
0.32
0.01*
0.02*
0.01*
0.95
0.65
0.22
0.03*

9.2%
3.2%
3.6%
4.2%
5.6%
4.4%
14.2%
16.5%
4.8%
5.6%
1.3%
14%

Beta
Device size
ASD minimum dimensions
ASD maximum dimensions
SVC rim
Aortic rim
Post rim
IVC rim
Associated morphological features
Shape of ASD
Position
Total aneurysm in diameter
Additional fenestrations in ﬂimsy rims

0.150.24
0.14
0.18
0.15
0.140.18
0.15
0.250.21
0.21
0.33-

Table 4. Comparison between Tunnel Length, Width, and Rims by 2DTEE and 3DTEE in PFO patients.
Tunnel dimensions
Length (mm)

Min.eMax
Mean ± SD.
Min.eMax
Mean ± SD.

Width (mm)
Rim dimensions
SVC Rim (mm)
Aortic Rim (mm)

MineMax
Mean ± SD
MineMax
Mean ± SD

3DTEE helped us in the exclusion of a patient
with left atrial pouch presenting clinically with
cryptogenic stroke, left atrial pouch is a blind
pouch that results from incomplete fusion between
primum and secundum septae allowing no shunt
across IAS, this patient had also a left atrial ridge
representing a thickened tissue on the left atrial
aspect of IAS, the patient was kept on anticoagulation. Subramaniam C. et al. reported left
atrial pouch in anatomical specimens due to tunnel
fusion only at its most caudal part [44]. Zisa et al.

2D TEE
(n ¼ 45)

3D TEE
(n ¼ 45)

Paired t test
P. value

9.0e18.0
11.81 þ 2.79
2.5e6.0
3.43 þ 0.74

8.5e20.0
12.08 þ 2.99
4.0e7.5
5.81 þ 0.65

1.8
(0.17)
7.75
(0.04*)

2D TEE
(n ¼ 45)

3D TEE
(n ¼ 45)

Paired t test
P. value

11e19
14.71 ± 2.55
8.5e11
9.76 ± 0.85

13e18
15.82 ± 1.76
8.5e12
9.91 ± 0.85

1.8
(0.17)
2.35
(0.47)

reported a case series of patients with abnormal
septal fusion patterns including the left atrial
pouch and ridge [45].
4.3. Procedural Guidance
3DTEE was used for monitoring of all procedural
steps; this is in agreement with Bushra S. Rana and
Balzer J. et al. who concluded that RT- 3DTEE was of
additional value while guiding the procedure over
2DTEE [46,47].

Table 5. Linear Regression Analysis of PFO parameters most affected by using 3DTEE.
Predictor variables

standardized coefﬁcients

T

P value

R square
(effect)

0.640.21
0.12
0.340.45
0.82
0.540.65
0.32
12.7

0.15
0.37
0.32
0.41
0.32
0.98
0.45
0.97
0.98
0.03*

4.2%
2.4%
4.6%
3.3%
2.7%
1.2%
1.3%
1.7%
1.2%
10.2%

Beta
Tunnel dimensions length
Tunnel dimensions width
Total aneurysmal minimum dimensions
Total aneurysmal maximum dimensions
Aortic Rim (mm)
Aortic Rim (mm)
ASA
EV
Dilated Aortic root
Additional fenestrations

0.190.25
0.47
0.140.36
0.21
0.140.18
0.23
0.36

The study has some limitations as it was conﬁned
to a single center and was restricted to patients more
than 15 kg as appropriate to the adult 3DTEE probe.

5. Conclusion
Due to complex 3D anatomy of IAS, 3DTEE provides incremental value to ASD/PFO assessment
and the surrounding fossa. 3DTEE enhances preprocedural planning and guidance through visualization of the position of catheters and devices relative to surrounding structures. This has improved
both safety and efﬁcacy of these procedures.
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